WSBC Form 4: Director Acquires Series B Depositary Shares in Offering
Rhea-AI Filing Summary
WesBanco, Inc. director Gregory S. Proctor Jr. reported a purchase of 2,000 depositary shares on 09/17/2025 at $25 per depositary share, increasing his direct beneficial ownership to 2,000 depositary shares. Each depositary share represents a 1/40th interest in a share of the companys 7.375% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B. The depositary shares were acquired in an underwritten public offering. The Form 4 was signed by an attorney-in-fact on 09/18/2025.
Positive
- Director purchase of 2,000 depositary shares shows insider participation in the underwritten offering
- Clear disclosure of security type and purchase price ($25 per depositary share) and legal execution
Negative
- None.
Insights
TL;DR: Director purchase of preferred depositary shares in an underwriting indicates insider participation but is limited in scale.
This filing documents a straightforward open-market acquisition through an underwritten public offering rather than a sale or derivative transaction. The purchase of 2,000 depositary shares at $25 each increases the reporting persons direct holdings to 2,000 depositary shares. Because each depositary share equals 1/40th of a preferred share, the economic stake in the preferred series is modest. There is no disclosure of related changes in common equity holdings, option exercises, or derivatives. The filing is procedural and does not indicate material changes to corporate control or capital structure.
TL;DR: Insider participation in the offering is a governance-positive signal but not material to ownership concentration.
The transaction shows a director acquiring preferred depositary shares via the companys underwritten offering, which can signal board-level support for the offering terms. The reported ownership remains limited to the 2,000 depositary shares and is held directly. The Form 4 contains clear identification of the security type and purchase mechanics and is properly executed by an attorney-in-fact. No director departures, option grants, or related-party transactions are disclosed in this filing.